Jushi Holdings (JUSHF) Intangibles (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Intangibles came in at $92.8 million in Q1 2026, down 6.19% year-on-year from $98.9 million in Q1 2025, and up 0.63% on a QoQ basis from $92.2 million in Q4 2025.
Jushi Holdings (JUSHF) Intangibles (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Intangibles data on file, last reported at $92.8 million in Q1 2026.
- On a quarterly basis, Intangibles fell 6.19% year-over-year to $92.8 million in Q1 2026; TTM through Mar 2026 was $92.8 million, a 6.19% decrease from a year earlier, with the FY2025 full-year figure at $92.2 million, down 8.23% from the prior year.
- Intangibles for Q1 2026 stood at $92.8 million, up from $92.2 million in the prior quarter.
- Over the last five years, Intangibles for JUSHF reached as high as $216.7 million in Q2 2022 and fell as low as $91.9 million in Q3 2024.
- Historically, Intangibles has averaged $114.3 million across 5 years, with a median of $97.6 million in 2023.
- Across the five-year window, Intangibles slumped 54.57% in 2023 and grew 4.69% in 2024, its largest moves.
- Year by year, Intangibles stood at $100.1 million in 2022, then declined by 4.11% to $96.0 million in 2023, then increased by 4.69% to $100.5 million in 2024, then decreased by 8.23% to $92.2 million in 2025, then grew by 0.63% to $92.8 million in 2026.
- Per Business Quant data, the three most recent Intangibles figures were $92.8 million in Q1 2026, $92.2 million in Q4 2025, and $94.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | 92.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 92.78 Mn |
| Dec 31, 2025 | 92.21 Mn |
| Sep 30, 2025 | 94.80 Mn |
| Jun 30, 2025 | 97.02 Mn |
| Mar 31, 2025 | 98.91 Mn |
| Dec 31, 2024 | 100.47 Mn |
| Sep 30, 2024 | 91.92 Mn |
| Jun 30, 2024 | 94.02 Mn |
| Mar 31, 2024 | 95.22 Mn |
| Dec 31, 2023 | 95.97 Mn |
| Sep 30, 2023 | 97.62 Mn |
| Jun 30, 2023 | 98.47 Mn |
| Mar 31, 2023 | 99.15 Mn |
| Dec 31, 2022 | 100.08 Mn |
| Sep 30, 2022 | 178.22 Mn |
| Jun 30, 2022 | 216.74 Mn |
| Mar 31, 2022 | 199.93 Mn |
| Dec 31, 2021 | 192.47 Mn |